Straits Times Index
3,402.16 +34.26 (+1.02%) Nikkei
40,398.20 +323.51 (+0.81%) Hang Seng
17,856.21 +87.07 (+0.49%) FTSE 100
8,121.20 -45.56 (-0.56%) Bitcoin USD
61,486.42 -1,383.50 (-2.20%) CMC Crypto 200
1,332.59 -11.92 (-0.89%)
PTGX Oct 2024 25.000 call
| Previous close | 9.02 |
| Open | 9.02 |
| Bid | 8.90 |
| Ask | 13.00 |
| Strike | 25.00 |
| Expiry date | 2024-10-18 |
| Day's range | 9.02 - 9.02 |
| Contract range | N/A |
| Volume | |
| Open interest | 6 |
PR NewswireProtagonist Therapeutics Set to Join S&P SmallCap 600
Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA (MTAA: PRY) is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.
Insider MonkeyIs Protagonist Therapeutics, Inc. (PTGX) a Good Healthcare Stock to Buy?
We recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we are going to take a look at where Protagonist Therapeutics, Inc. (NASDAQ:PTGX) stands against the other healthcare stocks under $50. If interested, you can also read our recent article on the 10 Best Healthcare Stocks To […]
Simply Wall St.We Think Some Shareholders May Hesitate To Increase Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) CEO Compensation
Key Insights Protagonist Therapeutics to hold its Annual General Meeting on 20th of June Salary of US$655.2k is part of...
